Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Amgen’s arthritis blockbuster Enbrel already owns an undesirable spot on the list of 10 drugs eligible for the first round of Medicare pricing negotiations. Now, the company is fighting back against a ...

The safety of etanercept in this patient population was established through multiple pediatric trials, including a clinical study in 69 children aged 2 to 17 years with moderately to severely active ...

Amgen said Friday it applied for clearance to begin using a manufacturing plant in Rhode Island to make rheumatoid arthritis treatment Enbrel. There has been a continuing problem with insufficient ...

Originally approved by the FDA in 1998, Amgen’s Enbrel is still sailing along without facing biosimilar competition in the United States. And unless a court rules otherwise, the Southern California ...

Getting your Trinity Audio player ready... A Colorado board voted to move forward with setting a price ceiling on the arthritis drug Enbrel on Friday, a first-in-the-nation step that raises questions ...

Getting your Trinity Audio player ready... Colorado became the first state in the country Friday to set a maximum price that insurers and patients can pay for a prescription medication — a move that’s ...

The U.S. government this week released the list of the 10 medications that will be the first to be the subject of the new price negotiations under the Medicare reform bill, and my arthritis drug, ...

The competing rheumatoid arthritis drugs of Immunex Corp. and Johnson & Johnson may offer effective new approaches to easing the chronic skin flares of psoriasis, new research shows. A study presented ...

LONDON -- Immunex Corp.'s top-selling rheumatoid arthritis drug Enbrel was linked to lupus in four patients at a Chicago hospital, according to a letter in this week's journal Lancet. The letter from ...

Generic drugmaker Sandoz (OTCQX:SDZXF) announced on Monday the filing of an antitrust lawsuit alleging that Amgen (NASDAQ:AMGN) used certain patent-related tactics to extend its U.S. market dominance ...